PharmaShots | Incisive News in 3 Shots

Subscribe Now

AstraZeneca

AstraZeneca to Highlight Tagrisso’s Clinical Data for NSCLC at ELCC 2025

AstraZeneca to Highlight Tagrisso’s Clinical Data for NSCLC at ELCC 2025

March 25, 2025

AstraZeneca Collaborates with Syneron Bio to Develop Macrocyclic Peptides for Chronic Diseases

AstraZeneca Collaborates with Syneron Bio to Develop Macrocyclic Peptides for Chronic Diseases

March 24, 2025

AstraZeneca Reports P-III (CALYPSO) Trial Data of Eneboparatide for Chronic Hypoparathyroidism (HypoPT)

AstraZeneca Reports P-III (CALYPSO) Trial Data of Eneboparatide for Chronic Hypoparathyroidism (HypoPT)

March 19, 2025

AstraZeneca to acquire EsoBiotec for ~$1B

AstraZeneca to acquire EsoBiotec for ~$1B

March 18, 2025

AstraZeneca Reports the EC’s Approval of Imfinzi to Treat Limited-Stage Small Cell Lung Cancer (LS-SCLC)

AstraZeneca Reports the EC’s Approval of Imfinzi to Treat Limited-Stage Small Cell Lung Cancer (LS-SCLC)

March 17, 2025

AstraZeneca and Alteogen Enter an Exclusive License Deal for ALT-B4 to Develop & Market Subcutaneous Formulations of Multiple Oncology Drugs

AstraZeneca and Alteogen Enter an Exclusive License Deal for ALT-B4 to Develop & Market Subcutaneous Formulations of Multiple Onco...

March 17, 2025

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us